Anosmia Market- Overview
Anosmia, a smell blindness, is the loss of the ability to smell. Anosmia may be temporary or permanent. Anosmia is regarded as a rare condition, but probably more common than many people think. According to the Fifth Sense, U.K., in 2020, various studies and survey performed in number of countries suggests that prevalence of smell loss worldwide is 0.1% to over 5%.
Global Anosmia Market – Impact of Coronavirus (COVID – 19) Pandemic
The COVID-19 pandemic is expected to hamper the global anosmia market growth during the forecast period. The COVID-19 pandemic and resulting lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare sector has been impacted majorly due to the COVID-19 pandemic. The shutdown has disrupted the supply, distribution, and manufacture of medical supplies globally.
Furthermore, the coronavirus pandemic has hampered the development, clinical trials, production, and supply of drugs and other healthcare products and also have affected growth of the healthcare businesses of various companies across the globe. According to the Indian Journal of Medical Sciences, June 6, 2020, the COVID-19 pandemic has affected the conduction of clinical trials due to unavailability of trial site staff, restrictions for travelling, investigational product availability, and others. As a result, the impact of the COVID-19 pandemic is expected to limit growth of the market during the forecast period.
Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/anosmia-market-4334
Increasing incidence of anosmia is expected to drive growth of the global anosmia market during the forecast period.
•Rising anosmia cases is expected to drive the anosmia market growth over the forecast period. For instance, according to an article published by the ENT UK at The Royal College of Surgeons of England in 2020, reports that novel COVID-19 virus causes anosmia in infected patients.

•Moreover, the same source, ENT UK at The Royal College of Surgeons of England in 2020, also reports that 30% of patients in South Korea, had anosmia. Similarly, according to the same source in Germany it is reported that more than 2 in 3 confirmed cases have anosmia.
Global Anosmia Market – Restraints
•Lack of approved drugs or therapeutics for the anosmia is the major factor that is expected to hinder the market growth. Currently, decongestants, antihistamines, and steroid nasal sprays are used off label for the treatment of the anosmia.

Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/4334
Global Anosmia Market – Regional Analysis
•On the basis of region, the global anosmia market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to dominate the global anosmia market during the forecast period, owing to increasing anosmia cases in the region. For instance, according to an article published by the National Center for Biotechnology Information (NCBI) in 2017, reports that anosmia affects 3.2% (3.4 million people) of U.S. adults, who are aged above 40 years.
Global Anosmia Market - Competitive Landscape
Some of the key players operating in the global anosmia market include Mylan N.V., Pfizer Inc., Atom Pharma, RANBAXY LABORATORIES LIMITED, Alde Medi Impex, GlaxoSmithkline plc, Sandoz (Novasrtis AG), Inke S.A., Taj Pharmaceuticals Limited, and Sanofi, amongst others.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4334
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837